Profund Advisors’s IDEAYA Biosciences IDYA Stock Holding History

Profund Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.31M	Sell	39,299 -7,816	-17%	-$262K	0.05%	276
2025 Q4	$1.63M	Buy	47,115 +26,424	+128%	+$842K	0.05%	257
2025 Q3	$563K	Sell	20,691 -2,684	-11%	-$64.9K	0.02%	473
2025 Q2	$491K	Sell	23,375 -2,257	-9%	-$43.3K	0.02%	469
2025 Q1	$420K	Buy	25,632 +2,031	+9%	+$43.3K	0.02%	535
2024 Q4	$607K	Sell	23,601 -1,973	-8%	-$55.9K	0.02%	420
2024 Q3	$810K	Buy	25,574 +2,751	+12%	+$104K	0.03%	376
2024 Q2	$801K	Sell	22,823 -9,099	-29%	-$360K	0.03%	361
2024 Q1	$1.4M	Sell	31,922 -54	-0.2%	-$2.32K	0.05%	257
2023 Q4	$1.14M	Buy	31,976 +9,633	+43%	+$288K	0.05%	303
2023 Q3	$603K	Sell	22,343 -929	-4%	-$23.6K	0.03%	414
2023 Q2	$547K	Sell	23,272 -788	-3%	-$16.2K	0.03%	485
2023 Q1	$330K	Buy	+24,060	New	+$401K	0.02%	669

Other funds holding IDYA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LGM

Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Profund Advisors's IDYA Position: Q1 2026 in Review

Profund Advisors reduced its IDEAYA Biosciences (IDYA) stake by 17% in Q1 2026, selling an estimated $262K and leaving 39,299 shares worth $1.31M. The position accounts for 0.05% of the portfolio, ranked #276.

Profund Advisors first reported a position in IDYA in Q1 2023 and has held it in 13 quarters since. The position peaked at $1.63M in Q4 2025. 253 funds tracked by Wall St. Rank hold IDYA as of Q1 2026.

Profund Advisors held 39,299 shares of IDEAYA Biosciences worth $1.31M as of Q1 2026.
Profund Advisors sold 7,816 IDEAYA Biosciences shares in Q1 2026, an estimated $262K.
IDEAYA Biosciences made up 0.05% of Profund Advisors's portfolio in Q1 2026, its #276 holding.
Profund Advisors first reported a position in IDEAYA Biosciences in Q1 2023 and has held it in 13 quarters since.
Profund Advisors's IDEAYA Biosciences position peaked at $1.63M in Q4 2025.
253 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2026.

Based on Profund Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.